U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160868) titled 'Obstructive Sleep Apnoea and Difficult Asthma (OSADA)' on Aug. 24.
Brief Summary: The OSADA (Obstructive Sleep Apnoea in Difficult Asthma) trial is an open-label, randomized control trial investigating the impact of diagnosing and treating obstructive sleep apnoea (OSA) on a asthma control in patients with difficult-to-control asthma.
Participants will undergo home-based sleep studies to assess for OSA and are then allocated to one of three arms: 1) Patients with OSA treated with CPAP (intervention group), 2) Patients with OSA not treated for OSA (control group) and 3) Patients without OSA (reference group).
The primary objective ...